Loading ...
Sorry, an error occurred while loading the content.

Fw: heptatitis - Achillion Pharmaceuticals and Beth Israel Deaconess Investigator Present Results of a Phase 1/2 Clinical Trial Demonstrating Potent Antiviral Activity Of New Anti-HBV Agent at ICAAC

Expand Messages
  • Patricia Jean
    heptatitis - Achillion Pharmaceuticals and Beth Israel Deaconess Investigator Present Results of a Phase 1/2 Clinical Trial Demonstrating Potent Antiviral
    Message 1 of 1 , Sep 29, 2002
    • 0 Attachment
      heptatitis - Achillion Pharmaceuticals and Beth Israel Deaconess Investigator Present Results of a Phase 1/2 Clinical Trial Demonstrating Potent Antiviral Activity Of New Anti-HBV Agent at ICAAC

      Edit News Alerts - Yahoo!
      --------------------------------------------------------------------------


      News Alert for "heptatitis"
      ADVERTISEMENT




      Achillion Pharmaceuticals and Beth Israel Deaconess Investigator Present Results of a Phase 1/2 Clinical Trial Demonstrating Potent Antiviral Activity Of New Anti-HBV Agent at ICAAC (PR Newswire)
      Demonstrating encouraging advances in the treatment of chronic hepatitis B virus infection, researchers at Beth Israel Deaconess today presented the first clinical data for Beta-L-Fd4C , Achillion Pharmaceuticals' novel L-nucleoside.

      --------------------------------------------------------------------------




      --------------------------------------------------------------------------------
      Researching? Search archived New York Times articles at Yahoo! News.

      Search News Stories Search News Photos

      --------------------------------------------------------------------------------
      If you no longer wish to receive this alert, click here to unsubscribe.
      If you have questions, send us feedback.

      --------------------------------------------------------------------------------
      Copyright © 1994-2002 Yahoo! Inc. All rights reserved. Yahoo Privacy Policy


      [Non-text portions of this message have been removed]
    Your message has been successfully submitted and would be delivered to recipients shortly.